On December 8, Bob Doll, Crossmark Global Investments CEO and CIO, joined CNBC’s ‘Squawk on the Street’ to discuss the latest market trends and his expectations for the Fed. Doll believes that the current situation is a high-risk bull market and emphasized that these words were chosen carefully. He explained the bull market component by noting that the path of least resistance for stocks is higher, especially when the Fed is cutting rates and earnings estimates are rising, which rarely results in stocks going down. He concluded the bull part by saying one has to be invested. The high-risk part, according to Doll, is due to the speculation taking place, high valuations, and other factors, leading him to expect persistent volatility.
In addressing the Fed specifically, Doll pointed out the extreme shifts in the market’s perceived probability of a rate cut, which has fluctuated wildly from an 80% chance to 30%, and then up to 90%, and suggested that nobody knows for certain what will happen, although it seems like they will lower rates. Doll discussed the inherent complexity of the situation: on one hand, doves might argue the Fed should hustle down to neutral rates, supported by an expectation of underlying disinflation next year. On the other hand, he noted the unusual nature of the Fed potentially cutting rates by a total of 1.75% in 15 months by the upcoming Wednesday without a recession really in sight. Doll characterized this as a tricky moment and called the 1.75% cut against no recession bizarre.
That being said, we’re here with a list of the 11 high short interest stocks to buy right now.
Our Methodology
We sifted through different stock screeners to compile a list of stocks with a short interest between 15% and 25%. We then selected 11 stocks that were the most popular among elite hedge funds and that analysts were bullish on. The stocks are ranked in ascending order of the number of hedge funds that have stakes in them, as of Q3 2025.
Note: All data was sourced on December 9.
Why are we interested in the stocks that hedge funds pile into? The reason is simple: our research has shown that we can outperform the market by imitating the top stock picks of the best hedge funds. Our quarterly newsletter’s strategy selects 14 small-cap and large-cap stocks every quarter and has returned 427.7% since May 2014, beating its benchmark by 264 percentage points (see more details here).
11 High Short Interest Stocks to Buy Right Now
11. The Campbell’s Company (NASDAQ:CPB)
Short % of Float as of November 14: 20.00%
Number of Hedge Fund Holders: 40
The Campbell’s Company (NASDAQ:CPB) is one of the high short interest stocks to buy right now. On December 10, Bernstein lowered the firm’s price target on Campbell’s Company to $33 from $39 and maintained an Outperform rating on the shares. According to Bernstein, the company’s product mix generally aligns with current consumer trends. Their Meals & Beverages division benefits from performance in broths and condensed soups. Premium brands like Pacifico and Rao’s also perform well due to their focus on high-quality ingredients. However, Ready-to-Serve soup is struggling due to the Well Yes! brand discontinuation.
A day prior, on December 9, Campbell’s Company announced its FQ1 earnings beat, with a Non-GAAP EPS of $0.77, surpassing analyst expectations by $0.04. Quarterly revenue reached $2.7 billion, which exceeded forecasts by $40 million, despite representing a 3% year-over-year decline.
In a strategic effort to support the growth of the company’s recently acquired Rao’s sauces brand (which was a deal that closed earlier in 2024), Campbell’s Company has entered into agreements to acquire a 49% interest in La Regina, the producer of the sauces. The company also reaffirmed its full fiscal year 2026 guidance, projecting an adjusted EPS between $2.40 and $2.55.
The Campbell’s Company (NASDAQ:CPB), together with its subsidiaries, manufactures and markets food and beverage products in the US and internationally. It operates through the Meals & Beverages and Snacks segments.
10. Oscar Health Inc. (NYSE:OSCR)
Short % of Float as of November 14: 13.91%
Number of Hedge Fund Holders: 40
Oscar Health Inc. (NYSE:OSCR) is one of the high short interest stocks to buy right now. On November 26, Piper Sandler analyst Jessica Tassan upgraded Oscar Health to Overweight from Neutral with a $25 price target, raised from $13. After a thorough analysis of benefit design, pricing, and broker strategy in Miami-Dade, which is Oscar’s largest county, Tassan believes that Oscar can simultaneously increase market share and profitability, even if the Enhanced Advance Premium Tax Credits/E-APTCs expire at the end of 2025. Piper Sandler views Oscar’s 2027 adjusted EBITDA of $404 million as the minimum expectation.
In its Q3 2025 earnings call, reported earlier the same month, Oscar Health announced a 23% year-over-year increase in total revenue, which reached ~$3 billion. Oscar also reported a strong increase in membership, ending the first 9 months of 2025 with more than 2 million members, which represents a 28% increase compared to the previous year. To enhance its market presence, Oscar Experience is now available in 20 states, including new entries into Alabama and Mississippi.
Additionally, the company is introducing innovative products, such as the Hello Meow plan for women experiencing menopause, and is using its health AI agent, called Oswell, to improve member health management and care paths. Looking ahead, Oscar Health anticipates a contraction in the overall market due to the expected expiration of enhanced premium tax credits and ongoing program integrity efforts. Consequently, the company expects a sequential decline in membership in Q4 due to historical churn patterns and the end of continuous monthly Special Enrollment Periods/SEP for certain income levels.
Oscar Health Inc. (NYSE:OSCR) operates as a healthcare technology company in the US. The company offers health plans to individuals, families, employees, and small group markets.
